- Email: [email protected]
Memorial sloan-kettering cancer center symposium on the diagnosis and treatment of bone tumors
b.u,,,p .'] (.'anger Vol. 15. PI' 28q 12qO Pergamon Prcss Ltd. 1979. P~intcd in Great Brmtm
Announcements SECOND N C I - E O R T C SYMPOSIUM ON NEW DRUGS IN CANCER THERAPY 18-20 ()ctober 1979, Institut Jules Border, Brussels, Belgium
Topics Cisplatin: a n c w agent in cancer chemotherapy (preclinical and clinical aspects) New investigational anticancer agents (Animal Screening, Epipodophyllotoxins, Neocarcinostatin, Nitrosoureas, Vindesine, m-AMSA, PALA, DDMP, Ellipticin, Thymidine, Methyl GAG, Carminomycir, Radiosensitizers).
With the participation of: P. ALBERTO (Geneva), M. AL-SARRAF (Detroit), R. BENJAMIN(Houston), G. P. BODEY (Houston), G. BONADONNA (Milan), A. BRU6AROLAS (Oviedo), F. CAVALH (Bellinzona), H. CORTES-FuNES (Madrid), P. J. CREAVEN (Buffalo), R. L. Cvsvz (Bethesda), R. DE JAOER (Bruxelles), R. T. EAt,AN (Rochester). R. GOLBEV (New York), A. GoLtnr~ (Bethesda), H. H. HANSEN (Copenhagen), K. HARaAP (Sutton), J. HILDEBRAND (Bruxelles), A. D. KELMAN (Boston), D. KISSER(Bethesda), J. KLASTERSKV(Bruxelles), J. P. MACQUET (Toulouse), G. MATHE (Villejuif), H. M. PXr~EDO (Ams'erdam), A. W. PRESTAVKO (Syracuse), G. RtWRA (Memphis), R. REGNIER (Bruxelles), J. J. ROBERTS (Chalfont St. Giles), B. ROSE.~BERO (East Lansing), M. ROZENCWEIC (Bruxelles), M. SAMSON (Detroit), S. SEI:'BER (Essen), R. SOMERS (Amsterdam), R. W. SOYNTAC; (Bern), M. STAQUE'r (Bruxelles), H. J. TAGNON (Bruxelles), M. L. TonE (London), D. D. vo.~ HoFr (San Antonio), S. WILLIAMS (Indianapolis), E. WXI.TSHAW (London), R. E. WITTES (New York) Free communications will be selected on the basis of submitted abstracts. Abstracts should be sent to the E O R T C Data Center before 31 August 1979. Registration will be granted to the first 200 applicants. Registration fee: 3000 Belgian francs (100 U.S. dollars). For further Juror:nation, contact Dr. M. Staquet or Dr. M. Rozencwcig, E()RTC Data Center, Institut Jules Border, 1 rue H6ger-Bordet, 1000 Brussels, Belgium. Phone: 538.57.90, Telex: 22773.
M E M O R I A L S L O A N - K E T T E R I N G CANCER CENTER SYMPOSIUM ON T H E DIAGNOSIS AND T R E A T M E N T OF BONE T U M O R S 17-18 November 1979, at Memorial Hospital, New York, N.Y. Experts in the various disciplines will present the latest available information on the pathology, radiographic diagnosis, scintigraphic imaging and the management of the patient with benign and malignant bone tumors at various stages of the disease. Also explored will be the importance of the modern interdisciplinary approach in the treatment. Attendance is open to physician only. There will be a $200 registration fee with advanced registration mandatory due to limited space availability. This continuing medical education activity meets the criteria for 13 credit hr in Category 1 of the Physician's Recognition Award of the American Medical Association. For further information write to: A. G. Huvos, M.D., Symposium Coordinator, Memorial Hospital, New York, N.Y. 10021, U.S.A.
1289
Announcements SECOND N C I - E O R T C SYMPOSIUM ON NEW DRUGS IN CANCER THERAPY 18-20 ()ctober 1979, Institut Jules Border, Brussels, Belgium
Topics Cisplatin: a n c w agent in cancer chemotherapy (preclinical and clinical aspects) New investigational anticancer agents (Animal Screening, Epipodophyllotoxins, Neocarcinostatin, Nitrosoureas, Vindesine, m-AMSA, PALA, DDMP, Ellipticin, Thymidine, Methyl GAG, Carminomycir, Radiosensitizers).
With the participation of: P. ALBERTO (Geneva), M. AL-SARRAF (Detroit), R. BENJAMIN(Houston), G. P. BODEY (Houston), G. BONADONNA (Milan), A. BRU6AROLAS (Oviedo), F. CAVALH (Bellinzona), H. CORTES-FuNES (Madrid), P. J. CREAVEN (Buffalo), R. L. Cvsvz (Bethesda), R. DE JAOER (Bruxelles), R. T. EAt,AN (Rochester). R. GOLBEV (New York), A. GoLtnr~ (Bethesda), H. H. HANSEN (Copenhagen), K. HARaAP (Sutton), J. HILDEBRAND (Bruxelles), A. D. KELMAN (Boston), D. KISSER(Bethesda), J. KLASTERSKV(Bruxelles), J. P. MACQUET (Toulouse), G. MATHE (Villejuif), H. M. PXr~EDO (Ams'erdam), A. W. PRESTAVKO (Syracuse), G. RtWRA (Memphis), R. REGNIER (Bruxelles), J. J. ROBERTS (Chalfont St. Giles), B. ROSE.~BERO (East Lansing), M. ROZENCWEIC (Bruxelles), M. SAMSON (Detroit), S. SEI:'BER (Essen), R. SOMERS (Amsterdam), R. W. SOYNTAC; (Bern), M. STAQUE'r (Bruxelles), H. J. TAGNON (Bruxelles), M. L. TonE (London), D. D. vo.~ HoFr (San Antonio), S. WILLIAMS (Indianapolis), E. WXI.TSHAW (London), R. E. WITTES (New York) Free communications will be selected on the basis of submitted abstracts. Abstracts should be sent to the E O R T C Data Center before 31 August 1979. Registration will be granted to the first 200 applicants. Registration fee: 3000 Belgian francs (100 U.S. dollars). For further Juror:nation, contact Dr. M. Staquet or Dr. M. Rozencwcig, E()RTC Data Center, Institut Jules Border, 1 rue H6ger-Bordet, 1000 Brussels, Belgium. Phone: 538.57.90, Telex: 22773.
M E M O R I A L S L O A N - K E T T E R I N G CANCER CENTER SYMPOSIUM ON T H E DIAGNOSIS AND T R E A T M E N T OF BONE T U M O R S 17-18 November 1979, at Memorial Hospital, New York, N.Y. Experts in the various disciplines will present the latest available information on the pathology, radiographic diagnosis, scintigraphic imaging and the management of the patient with benign and malignant bone tumors at various stages of the disease. Also explored will be the importance of the modern interdisciplinary approach in the treatment. Attendance is open to physician only. There will be a $200 registration fee with advanced registration mandatory due to limited space availability. This continuing medical education activity meets the criteria for 13 credit hr in Category 1 of the Physician's Recognition Award of the American Medical Association. For further information write to: A. G. Huvos, M.D., Symposium Coordinator, Memorial Hospital, New York, N.Y. 10021, U.S.A.
1289